Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-088369
Filing Date
2023-08-07
Accepted
2023-08-07 16:23:17
Documents
6
Effectiveness Date
2023-08-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2322302d1_s8.htm S-8 40312
2 EXHIBIT 5.1 tm2322302d1_ex5-1.htm EX-5.1 11052
3 EXHIBIT 23.2 tm2322302d1_ex23-2.htm EX-23.2 3325
4 EX-FILING FEES tm2322302d1_ex-filingfees.htm EX-FILING FEES 9988
5 GRAPHIC tm2322302d1_ex5-1img001.jpg GRAPHIC 2729
6 GRAPHIC tm2322302d1_ex5-1img002.jpg GRAPHIC 2710
  Complete submission text file 0001104659-23-088369.txt   73581
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273766 | Film No.: 231147931
SIC: 2836 Biological Products, (No Diagnostic Substances)